Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 49,204,800
- Share change
- +2,357,782
- Total reported value
- $1,682,561,970
- Put/Call ratio
- 53%
- Price per share
- $34.20
- Number of holders
- 144
- Value change
- +$93,460,895
- Number of buys
- 84
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
10%
|
6,492,638
|
$115,049,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
7%
|
4,387,300
|
$77,743,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
6.2%
|
3,901,759
|
$69,139,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
3,199,496
|
$56,695,000 | — | 30 Sep 2021 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.9%
|
2,449,183
|
$43,400,000 | — | 30 Sep 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.8%
|
2,392,000
|
$42,386,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
2,353,786
|
$41,710,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
2,013,979
|
$35,688,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
1,753,695
|
$31,075,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
2.4%
|
1,500,000
|
$26,580,000 | — | 30 Sep 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.3%
|
1,443,800
|
$25,584,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.2%
|
1,394,000
|
$24,702,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
875,732
|
$15,518,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
823,290
|
$14,588,000 | — | 30 Sep 2021 | |
| Obermeyer Wealth Partners |
13F
|
Company |
1.2%
|
776,689
|
$13,763,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
728,930
|
$12,916,000 | — | 30 Sep 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
550,083
|
$9,747,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.84%
|
522,871
|
$9,265,000 | — | 30 Sep 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.8%
|
498,079
|
$8,826,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.79%
|
491,641
|
$8,712,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.76%
|
474,306
|
$8,405,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
456,977
|
$8,098,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.69%
|
428,695
|
$7,597,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
423,195
|
$7,499,000 | — | 30 Sep 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.55%
|
346,000
|
$6,131,000 | — | 30 Sep 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.53%
|
330,222
|
$5,852,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
309,832
|
$5,491,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.48%
|
300,045
|
$5,317,000 | — | 30 Sep 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.48%
|
297,709
|
$5,275,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.43%
|
267,383
|
$4,738,000 | — | 30 Sep 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.42%
|
260,379
|
$4,614,000 | — | 30 Sep 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.35%
|
218,936
|
$3,880,000 | — | 30 Sep 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.35%
|
217,483
|
$3,854,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
145,300
|
$2,575,000 | — | 30 Sep 2021 | |
| Twin Lakes Capital Management, LLC |
13F
|
Company |
0.22%
|
139,287
|
$2,468,000 | — | 30 Sep 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.21%
|
131,282
|
$2,326,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
131,133
|
$2,324,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
118,704
|
$2,104,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.19%
|
115,913
|
$2,054,000 | — | 30 Sep 2021 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
112,265
|
$1,989,000 | — | 30 Sep 2021 | |
| Caption Management, LLC |
13F
|
Company |
0.18%
|
110,000
|
$1,949,000 | — | 30 Sep 2021 | |
| JABODON PT CO |
13F
|
Company |
0.15%
|
90,656
|
$1,606,000 | — | 30 Sep 2021 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.14%
|
90,000
|
$1,595,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
87,400
|
$1,549,000 | — | 30 Sep 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.14%
|
86,237
|
$1,528,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.13%
|
83,646
|
$1,482,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.12%
|
77,002
|
$1,363,000 | — | 30 Sep 2021 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.11%
|
71,343
|
$1,264,000 | — | 30 Sep 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
71,200
|
$1,262,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
163,086
|
$1,261,000 | — | 30 Sep 2021 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q4 2021
As of 31 Dec 2021,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,204,800 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, BlackRock Inc., EcoR1 Capital, LLC, RTW INVESTMENTS, LP, STATE STREET CORP, JOHNSON & JOHNSON, Point72 Asset Management, L.P., VANGUARD GROUP INC, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
145
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
126
Q4 2021 holders
144
Holder diff
18
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.